The future of metabolomics in ELIXIR
-
Published:2017-10-30
Issue:
Volume:6
Page:1649
-
ISSN:2046-1402
-
Container-title:F1000Research
-
language:en
-
Short-container-title:F1000Res
Author:
van Rijswijk MerlijnORCID, Beirnaert CharlieORCID, Caron Christophe, Cascante Marta, Dominguez VictoriaORCID, Dunn Warwick B., Ebbels Timothy M. D., Giacomoni Franck, Gonzalez-Beltran AlejandraORCID, Hankemeier Thomas, Haug KennethORCID, Izquierdo-Garcia Jose L., Jimenez Rafael C.ORCID, Jourdan Fabien, Kale NamrataORCID, Klapa Maria I.ORCID, Kohlbacher OliverORCID, Koort Kairi, Kultima Kim, Le Corguillé GildasORCID, Moreno Pablo, Moschonas Nicholas K.ORCID, Neumann Steffen, O’Donovan Claire, Reczko Martin, Rocca-Serra Philippe, Rosato AntonioORCID, Salek Reza M.ORCID, Sansone Susanna-AssuntaORCID, Satagopam VenkataORCID, Schober DanielORCID, Shimmo Ruth, Spicer Rachel A.ORCID, Spjuth OlaORCID, Thévenot Etienne A.ORCID, Viant Mark R., Weber Ralf J. M., Willighagen Egon L.ORCID, Zanetti Gianluigi, Steinbeck ChristophORCID
Abstract
Metabolomics, the youngest of the major omics technologies, is supported by an active community of researchers and infrastructure developers across Europe. To coordinate and focus efforts around infrastructure building for metabolomics within Europe, a workshop on the “Future of metabolomics in ELIXIR” was organised at Frankfurt Airport in Germany. This one-day strategic workshop involved representatives of ELIXIR Nodes, members of the PhenoMeNal consortium developing an e-infrastructure that supports workflow-based metabolomics analysis pipelines, and experts from the international metabolomics community. The workshop established metabolite identification as the critical area, where a maximal impact of computational metabolomics and data management on other fields could be achieved. In particular, the existing four ELIXIR Use Cases, where the metabolomics community - both industry and academia - would benefit most, and which could be exhaustively mapped onto the current five ELIXIR Platforms were discussed. This opinion article is a call for support for a new ELIXIR metabolomics Use Case, which aligns with and complements the existing and planned ELIXIR Platforms and Use Cases.
Funder
Horizon 2020 Framework Programme
Publisher
F1000 Research Ltd
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|